Abstract: A paper product may include high energy thermomechanical pulp (TMP), low energy TMP, and microfibrillated cellulose. The paper product may also include inorganic particulate material. A papermaking composition suitable for making the paper product, a process for preparing the paper product, and use of microfibrillated cellulose may include high energy TMP, low energy TMP, and microfibrillated cellulose, and optionally inorganic particulate material. The microfibrillated cellulose may have a fibre steepness of from about 20 to about 50 in the paper product.

Abstract: A method for preparing an aqueous suspension may include providing a fibrous substrate comprising cellulose having a Canadian Standard freeness equal to or less than 450 cm3, and microfibrillating the fibrous substrate in an aqueous environment by grinding in the presence of a grinding medium consisting essentially of mullite. The grinding may be carried out in the absence of grindable inorganic particulate material. The grinding medium may be present in an amount of at least about 10% by volume of the aqueous environment. The microfibrillated cellulose may have a fibre steepness of from about 20 to about 50.

Abstract: A paper product may include high energy thermomechanical pulp (TMP), low energy TMP, and microfibrillated cellulose. The paper product may also include inorganic particulate material. A papermaking composition suitable for making the paper product, a process for preparing the paper product, and use of microfibrillated cellulose may include high energy TMP, low energy TMP, and microfibrillated cellulose, and optionally inorganic particulate material. The microfibrillated cellulose may have a fiber steepness of from about 20 to about 50 in the paper product.

Abstract: A method for preparing an aqueous suspension may include providing a fibrous substrate comprising cellulose having a Canadian Standard freeness equal to or less than 700 cm3, and microfibrillating the fibrous substrate in an aqueous environment by grinding in the presence of a grinding medium which is to be removed after completion of grinding. The grinding may be carried out in the absence of grindable inorganic particulate material, wherein the grinding medium is present in an amount of at least about 10% by volume of the aqueous environment, and wherein the microfibrillated cellulose has a fiber steepness of from about 20 to about 50.

Abstract: A pipette may comprise a length, a longitudinal axis, and an inner curved surface enclosing a space. The pipette may have a tip region having a tip thickness. The tip region may be connected to a body region having a body thickness. The tip thickness may be greater than the body thickness. The body region may be connected to a mouth region having a mouth thickness. The mouth thickness may be greater than the body thickness. The inner curved surface may not contain bumps or ridges either between the tip region and the body region or between the body region and the mouth region. The pipette may be formed by blow molding or vacuum forming.

Abstract: A pipette may comprise a length, a longitudinal axis, and an inner curved surface enclosing a space. The pipette may have a tip region having a tip thickness. The tip region may be connected to a body region having a body thickness. The tip thickness may be greater than the body thickness. The body region may be connected to a mouth region having a mouth thickness. The mouth thickness may be greater than the body thickness. The inner curved surface may not contain bumps or ridges either between the tip region and the body region or between the body region and the mouth region. The pipette may be formed by blow molding or vacuum forming.

Abstract: A pipette tip includes a proximal end having an aperture and a proximal body region having a first internal cavity that receives a pipette member, and a distal end having an aperture and a distal body region having a second internal cavity that in operation receives and discharges a liquid aspirated by the pipette member, where the ratio of the proximal half weight of the pipette tip to the distal half weight of the pipette tip normalized to the total weight of the pipette tip has a value, defined as a thinning constant, wherein the pipette tip has a wall thickness of less than 0.022 inches over the distal region.

Abstract: A serological pipette has an elongated hollow tubular body having an optical transmission of 40 to 70% over a range of 390 to 700 nm. The pipette body is formed from a polymer composition that includes 5 to 30 wt. % poly(styrene-butadiene-styrene) and 70 to 95 wt. % polystyrene. The tubular body is formed by extrusion at a barrel temperature ranging from 400 to 500F.

Abstract: A magnetically driven pressure generator including a housing, flexible member, first magnetic force generator, and second magnetic force generator. The magnetically driven pressure generator oscillates the flexible member to increase or decrease the volume of a chamber, inversely increasing or decreasing the pressure of the chamber.

Abstract: A pharmaceutical composition or formulation adapted for oral administration in tablet, coated tablet, capsule or reconstitutable powder form for the prevention or treatment of intestinal disorders such irritable bowel syndrome, also known as irritable colon syndrome, based on an intestinal motility modifier, an agent that prevents gas retention, of digestive enzymes, a binding agent, a diluting agent, an absorbent agent, a lubricant, aglidant, and an disintegrating agent or suspending agent, effective in the normalization of intestinal disorders, to achieve an analgesic activity, to achieve an anti-spasmic activity and to reduce the symptoms associated with intestinal gas such as distention, abdominal pain and flatulence.

Abstract: Compositions such as filled and coated papers may include microfibrillated cellulose and inorganic particulate material.

Abstract: A method for preparing an aqueous suspension may include providing a fibrous substrate comprising cellulose having a Canadian Standard freeness equal to or less than 700 cm3, and microfibrillating the fibrous substrate in an aqueous environment by grinding in the presence of a grinding medium which is to be removed after completion of grinding. The grinding may be carried out in the absence of grindable inorganic particulate material, wherein the grinding medium is present in an amount of at least about 10% by volume of the aqueous environment, and wherein the microfibrillated cellulose has a fibre steepness of from about 20 to about 50.

Abstract: A paper product may include high energy thermomechanical pulp (TMP), low energy TMP, and microfibrillated cellulose. The paper product may also include inorganic particulate material. A papermaking composition suitable for making the paper product, a process for preparing the paper product, and use of microfibrillated cellulose may include high energy TMP, low energy TMP, and microfibrillated cellulose, and optionally inorganic particulate material. The microfibrillated cellulose may have a fibre steepness of from about 20 to about 50 in the paper product.

Abstract: A method for preparing an aqueous suspension comprising microfibrillated cellulose and inorganic particulate material, the method comprising a step of microfibrillating a fibrous substrate comprising cellulose in an aqueous environment in the presence of an inorganic particulate material.

Abstract: The invention relates to a pharmaceutical formulation or composition in the form of a tablet, coated tablet, capsule or powder tor reconstitution, for use in irritable bowel syndrome, comprising an intestinal motility modifier and enzyme ?-D-galactosidase.

Abstract: The invention provides improved methods for modifying collagenous tissues, particularly for treating urinary incontinence in a noninvasive manner. The methods typically include inserting a probe into a patient's urethra, transmitting electromagnetic energy from the probe to a collagneous target tissue, and cooling the tissue in the vicinity of the probe. The probe may include an expandable element at or near the distal end that is configured to expand within the patient's bladder. The expandable element may anchor the probe before or during treatment.

Abstract: A method of making a microplate, including: injection molding a resin to form a substrate (900) having a grating region feature on a surface of the substrate, and at least one micro-feature (910) in the vicinity of the grating region feature; waveguide treating (920) the resulting molded substrate; and over-molding the resulting waveguide treated molded substrate with a compatible resin to from the integral well plate (935) on the microplate. Also disclosed is a method of making a microplate, including: surface roughening to form a bonding area on a waveguide coated surface of a polymeric substrate having an integral grating region; and over-molding the resulting surface roughened substrate and a compatible resin to form the integral microplate, as defined herein.

Abstract: A resonant waveguide article, including: a polymeric substrate having at least one integral grating region, wherein the article has a low birefringence property of for example, from about 5 to 270 nm/cm, as defined herein. Also disclosed is a microplate including the resonant waveguide article, and an integral well plate bonded to the sensor article, as defined herein. Also disclosed are methods of making a sensor article, and a method of making and using the microplate including the sensor article, as defined herein.

Abstract: Many image guided needle procedures use ultrasound, computed tomography (CT) magnetic resonance imaging (MRI) or other imaging systems. In such procedures, there is currently a preference for long axis injections and related procedures where the long axis of the needle is parallel to the plane of the two dimensional images created by the imaging system. This is due to the fact that long axis imaging of a needle provides good visual indication of depth of penetration of the needle, whereas short axis imaging shows only a dot or small circle, which is the cross section of the needle and provides no depth of penetration information. Many procedures, however, benefit from, or require the use of, short axis imaging. The depth advancement marker needle of the present invention provides a feature along the shaft of the needle that provides a visual indicator of depth of penetration while performing short axis imaging.

Abstract: Compositions such as filled and coated papers may include microfibrillated cellulose and inorganic particulate material.